BLINATUMOMAB

BLINATUMOMAB was reported 10722 times

These side effects are most commonly reported by patients taking BLINATUMOMAB:

# Side effect Count
0 PYREXIA 1187
1 CYTOKINE RELEASE SYNDROME 1150
2 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1121
3 OFF LABEL USE 793
4 DEATH 674
5 NEUROTOXICITY 584
6 DRUG INEFFECTIVE 448
7 HEADACHE 379
8 NEUTROPENIA 333
9 FEBRILE NEUTROPENIA 313
10 THERAPY NON-RESPONDER 291
11 TREMOR 287
12 SEIZURE 279
13 INFECTION 268
14 ACUTE LYMPHOCYTIC LEUKAEMIA 251
15 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 242
16 THROMBOCYTOPENIA 234
17 CONFUSIONAL STATE 232
18 CENTRAL NERVOUS SYSTEM LEUKAEMIA 204
19 PNEUMONIA 201
20 ACCIDENTAL EXPOSURE TO PRODUCT 198
21 PRODUCT STORAGE ERROR 196
22 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 193
23 DISEASE PROGRESSION 192
24 SEPSIS 192
25 B PRECURSOR TYPE ACUTE LEUKAEMIA 172
26 NERVOUS SYSTEM DISORDER 167
27 ANAEMIA 164
28 HYPOTENSION 162
29 NAUSEA 161
30 PLATELET COUNT DECREASED 160
31 PANCYTOPENIA 157
32 VOMITING 153
33 FATIGUE 150
34 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 149
35 RASH 148
36 MYELOSUPPRESSION 143
37 ENCEPHALOPATHY 142
38 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 142
39 APHASIA 139
40 B-CELL TYPE ACUTE LEUKAEMIA 139
41 HEPATOTOXICITY 130
42 NEUROPATHY PERIPHERAL 125
43 NEUTROPHIL COUNT DECREASED 125
44 ALANINE AMINOTRANSFERASE INCREASED 124
45 BLAST CELL COUNT INCREASED 122
46 ACUTE GRAFT VERSUS HOST DISEASE 119
47 ASTHENIA 119
48 VENOOCCLUSIVE LIVER DISEASE 119
49 TREATMENT FAILURE 116
50 WHITE BLOOD CELL COUNT DECREASED 113
51 INTERCEPTED PRODUCT PREPARATION ERROR 111
52 COVID-19 110
53 DIARRHOEA 110
54 CYTOPENIA 109
55 PRODUCT PREPARATION ERROR 107
56 GRAFT VERSUS HOST DISEASE 106
57 CHILLS 104
58 TACHYCARDIA 104
59 MULTIPLE ORGAN DYSFUNCTION SYNDROME 103
60 MINIMAL RESIDUAL DISEASE 102
61 HOSPITALISATION 98
62 DEVICE RELATED INFECTION 96
63 TOXICITY TO VARIOUS AGENTS 96
64 SOMNOLENCE 95
65 ADVERSE EVENT 94
66 DYSPNOEA 94
67 MALAISE 93
68 PLEURAL EFFUSION 92
69 CYTOMEGALOVIRUS INFECTION 91
70 ACUTE KIDNEY INJURY 90
71 TUMOUR LYSIS SYNDROME 90
72 HYPERTENSION 88
73 UNEVALUABLE EVENT 87
74 ASPARTATE AMINOTRANSFERASE INCREASED 86
75 ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY 84
76 CHRONIC GRAFT VERSUS HOST DISEASE 81
77 RESPIRATORY FAILURE 81
78 DISEASE RECURRENCE 80
79 ARTHRALGIA 79
80 PAIN 79
81 HEPATIC ENZYME INCREASED 78
82 HYPOGAMMAGLOBULINAEMIA 78
83 GRAFT VERSUS HOST DISEASE IN SKIN 76
84 HEPATIC FUNCTION ABNORMAL 75
85 BLOOD BILIRUBIN INCREASED 73
86 INFUSION SITE HAEMORRHAGE 73
87 PAIN IN EXTREMITY 72
88 SEPTIC SHOCK 72
89 DISORIENTATION 71
90 VENOOCCLUSIVE DISEASE 71
91 TRANSAMINASES INCREASED 70
92 BONE MARROW FAILURE 69
93 DIZZINESS 68
94 DISSEMINATED INTRAVASCULAR COAGULATION 66
95 MALIGNANT NEOPLASM PROGRESSION 66
96 STOMATITIS 66
97 WHITE BLOOD CELL COUNT INCREASED 66
98 HYPERGLYCAEMIA 65
99 HYPOXIA 65
100 OCCUPATIONAL EXPOSURE TO PRODUCT 65
101 ABDOMINAL PAIN 64
102 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 64
103 LEUKOPENIA 64
104 DYSARTHRIA 63
105 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 62
106 DELIRIUM 61
107 HYPOKALAEMIA 61
108 MENTAL STATUS CHANGES 61
109 MUCOSAL INFLAMMATION 61
110 RENAL IMPAIRMENT 60
111 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 57
112 HYPOAESTHESIA 57
113 MUSCULAR WEAKNESS 57
114 NEUROLOGICAL SYMPTOM 57
115 RHEUMATOID ARTHRITIS 57
116 THERAPY PARTIAL RESPONDER 57
117 INTERCEPTED PRODUCT ADMINISTRATION ERROR 56
118 LIVER FUNCTION TEST INCREASED 56
119 NEOPLASM PROGRESSION 56
120 PANCREATITIS 56
121 BACK PAIN 55
122 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 55
123 MYALGIA 54
124 BLOOD LACTATE DEHYDROGENASE INCREASED 53
125 DRUG INTOLERANCE 52
126 DRUG RESISTANCE 52
127 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 52
128 GAIT DISTURBANCE 51
129 SPEECH DISORDER 51
130 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 51
131 C-REACTIVE PROTEIN INCREASED 50
132 GENERALISED TONIC-CLONIC SEIZURE 50
133 CONSTIPATION 49
134 DECREASED APPETITE 49
135 LEUKAEMIA RECURRENT 49
136 LIVER DISORDER 49
137 BONE PAIN 48
138 PRODUCT DOSE OMISSION ISSUE 48
139 EPILEPSY 47
140 MEMORY IMPAIRMENT 47
141 BACTERAEMIA 46
142 CEREBRAL HAEMORRHAGE 46
143 HAEMOGLOBIN DECREASED 46
144 LYMPHOCYTE COUNT DECREASED 46
145 CONDITION AGGRAVATED 45
146 FUNGAL INFECTION 44
147 PARAESTHESIA 44
148 HEPATIC FAILURE 43
149 INCORRECT DRUG ADMINISTRATION RATE 43
150 ALTERED STATE OF CONSCIOUSNESS 42
151 INCORRECT DOSE ADMINISTERED 42
152 ASPERGILLUS INFECTION 41
153 COUGH 41
154 HAEMORRHAGE 41
155 HALLUCINATION 40
156 PRODUCT USE IN UNAPPROVED INDICATION 40
157 RENAL FAILURE 40
158 GENERAL PHYSICAL HEALTH DETERIORATION 39
159 LEUKOENCEPHALOPATHY 39
160 STAPHYLOCOCCAL INFECTION 39
161 TRANSPLANTATION COMPLICATION 39
162 BLOOD GLUCOSE INCREASED 38
163 CARDIAC FAILURE 38
164 FALL 38
165 WEIGHT DECREASED 38
166 FULL BLOOD COUNT DECREASED 37
167 GAMMA-GLUTAMYLTRANSFERASE INCREASED 37
168 HAEMATOTOXICITY 37
169 THROMBOTIC MICROANGIOPATHY 37
170 ANXIETY 36
171 COLITIS 36
172 INFUSION RELATED REACTION 36
173 NEOPLASM RECURRENCE 36
174 DEPRESSED LEVEL OF CONSCIOUSNESS 35
175 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 35
176 LINEAGE SWITCH LEUKAEMIA 35
177 ADVERSE DRUG REACTION 34
178 BLOOD PRESSURE DECREASED 34
179 DEVICE OCCLUSION 34
180 EPISTAXIS 34
181 LABORATORY TEST ABNORMAL 34
182 SYNCOPE 34
183 ASCITES 33
184 ATAXIA 33
185 DYSGRAPHIA 33
186 INJECTION SITE HAEMORRHAGE 33
187 LOSS OF CONSCIOUSNESS 33
188 URINARY TRACT INFECTION 33
189 B-CELL APLASIA 32
190 BODY TEMPERATURE INCREASED 32
191 CEREBROVASCULAR ACCIDENT 32
192 ILL-DEFINED DISORDER 32
193 ADVERSE REACTION 31
194 ATRIAL FIBRILLATION 31
195 BONE MARROW LEUKAEMIC CELL INFILTRATION 31
196 CARDIOTOXICITY 31
197 COGNITIVE DISORDER 31
198 CYTOMEGALOVIRUS INFECTION REACTIVATION 31
199 ESCHERICHIA BACTERAEMIA 31
200 HEART RATE INCREASED 31
201 INTERSTITIAL LUNG DISEASE 31
202 LIVER INJURY 31
203 OEDEMA 31
204 PERICARDIAL EFFUSION 31
205 PNEUMONIA FUNGAL 31
206 PULMONARY OEDEMA 31
207 NEUTROPENIC SEPSIS 30
208 PHILADELPHIA CHROMOSOME POSITIVE 30
209 PULMONARY EMBOLISM 30
210 UPPER RESPIRATORY TRACT INFECTION 30
211 AGITATION 29
212 CHEST PAIN 29
213 DEEP VEIN THROMBOSIS 29
214 ACUTE MYELOID LEUKAEMIA 28
215 BLAST CELLS PRESENT 28
216 BLOOD ALKALINE PHOSPHATASE INCREASED 28
217 LETHARGY 28
218 OXYGEN SATURATION DECREASED 28
219 STATUS EPILEPTICUS 28
220 ACUTE RESPIRATORY FAILURE 27
221 FEELING ABNORMAL 27
222 HEMIPARESIS 27
223 LUNG DISORDER 27
224 LYMPHADENOPATHY 27
225 LYMPHOPENIA 27
226 MENTAL DISORDER 27
227 PRURITUS 27
228 PSEUDOMONAS INFECTION 27
229 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 26
230 BALANCE DISORDER 26
231 BK VIRUS INFECTION 26
232 CLOSTRIDIUM DIFFICILE COLITIS 26
233 CLOSTRIDIUM DIFFICILE INFECTION 26
234 GASTROINTESTINAL DISORDER 26
235 INSOMNIA 26
236 PRODUCT USE ISSUE 26
237 THERAPY INTERRUPTED 26
238 ACUTE RESPIRATORY DISTRESS SYNDROME 25
239 BLOOD PRESSURE INCREASED 25
240 COAGULOPATHY 25
241 DEHYDRATION 25
242 DRY SKIN 25
243 GENE MUTATION 25
244 OVERDOSE 25
245 PNEUMOCYSTIS JIROVECII PNEUMONIA 25
246 UNRESPONSIVE TO STIMULI 25
247 BACTERIAL INFECTION 24
248 BRONCHOPULMONARY ASPERGILLOSIS 24
249 CAPILLARY LEAK SYNDROME 24
250 CHOLESTASIS 24
251 COVID-19 PNEUMONIA 24
252 DEVICE LEAKAGE 24
253 HYPOCALCAEMIA 24
254 PERIPHERAL SENSORY NEUROPATHY 24
255 RHINOVIRUS INFECTION 24
256 STAPHYLOCOCCAL BACTERAEMIA 24
257 THROMBOSIS 24
258 TUBULOINTERSTITIAL NEPHRITIS 24
259 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 23
260 ADENOVIRUS INFECTION 23
261 CANDIDA INFECTION 23
262 FACIAL PARALYSIS 23
263 GRAFT VERSUS HOST DISEASE IN LIVER 23
264 HAEMORRHAGE INTRACRANIAL 23
265 HYPERPHOSPHATAEMIA 23
266 OSTEONECROSIS OF JAW 23
267 RESPIRATORY DISTRESS 23
268 SERUM FERRITIN INCREASED 23
269 THROMBOSIS IN DEVICE 23
270 ABDOMINAL PAIN UPPER 22
271 BRAIN OEDEMA 22
272 DRUG INTERACTION 22
273 END STAGE RENAL DISEASE 22
274 FUSARIUM INFECTION 22
275 MUSCLE SPASMS 22
276 MUSCLE TWITCHING 22
277 MYELODYSPLASTIC SYNDROME 22
278 PERIPHERAL SWELLING 22
279 COMA 21
280 CYSTITIS HAEMORRHAGIC 21
281 DEVICE INFUSION ISSUE 21
282 DRUG-INDUCED LIVER INJURY 21
283 DYSPHAGIA 21
284 FLUSHING 21
285 HYPERTRANSAMINASAEMIA 21
286 HYPERTRIGLYCERIDAEMIA 21
287 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 21
288 INTERCEPTED MEDICATION ERROR 21
289 OEDEMA PERIPHERAL 21
290 PRODUCT ADMINISTRATION ERROR 21
291 SHOCK 21
292 SINUSITIS 21
293 SYSTEMIC MYCOSIS 21
294 TRANSPLANT FAILURE 21
295 BLOOD CREATININE INCREASED 20
296 CARDIAC ARREST 20
297 EOSINOPHILIA 20
298 ERYTHEMA 20
299 GASTROINTESTINAL HAEMORRHAGE 20
300 HERPES SIMPLEX 20
301 HYPERBILIRUBINAEMIA 20
302 HYPERHIDROSIS 20
303 HYPONATRAEMIA 20
304 SUBDURAL HAEMATOMA 20
305 APRAXIA 19
306 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 19
307 EMBOLISM 19
308 ENTEROCOCCAL INFECTION 19
309 FUNGAEMIA 19
310 HYPERAMMONAEMIA 19
311 LEUKOCYTOSIS 19
312 MUCORMYCOSIS 19
313 PANCREATITIS ACUTE 19
314 PNEUMONITIS 19
315 RASH MACULO-PAPULAR 19
316 AMNESIA 18
317 BLOOD COUNT ABNORMAL 18
318 DEVICE ISSUE 18
319 DEVICE RELATED THROMBOSIS 18
320 DRUG EFFECT INCOMPLETE 18
321 ESCHERICHIA URINARY TRACT INFECTION 18
322 HEPATIC CYTOLYSIS 18
323 HERPES ZOSTER 18
324 LIVER FUNCTION TEST ABNORMAL 18
325 THERAPEUTIC RESPONSE DECREASED 18
326 VISION BLURRED 18
327 VISUAL IMPAIRMENT 18
328 WEIGHT INCREASED 18
329 WHITE BLOOD CELL COUNT ABNORMAL 18
330 ALOPECIA 17
331 APNOEA 17
332 BLOOD IMMUNOGLOBULIN G DECREASED 17
333 BRADYCARDIA 17
334 BURKITT^S LYMPHOMA RECURRENT 17
335 CELLULITIS 17
336 CORONAVIRUS INFECTION 17
337 CSF CELL COUNT INCREASED 17
338 HEPATIC ENCEPHALOPATHY 17
339 NON-HODGKIN^S LYMPHOMA 17
340 OLIGURIA 17
341 ACUTE BIPHENOTYPIC LEUKAEMIA 16
342 ASPIRATION BONE MARROW ABNORMAL 16
343 COMPLICATION ASSOCIATED WITH DEVICE 16
344 DEMENTIA 16
345 ENCEPHALITIS 16
346 HAEMATURIA 16
347 HYPERSENSITIVITY 16
348 IMMUNODEFICIENCY 16
349 INFLAMMATION 16
350 LEUKAEMIA 16
351 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 16
352 PRODUCT LEAKAGE 16
353 PULMONARY HAEMORRHAGE 16
354 SHOCK HAEMORRHAGIC 16
355 SPLENOMEGALY 16
356 BABESIOSIS 15
357 BACTERIAL SEPSIS 15
358 DIFFUSE LARGE B-CELL LYMPHOMA 15
359 INFLUENZA 15
360 INTRACRANIAL PRESSURE INCREASED 15
361 LEUKAEMIA CUTIS 15
362 LUNG INFILTRATION 15
363 NEURALGIA 15
364 PLATELET COUNT ABNORMAL 15
365 PRECURSOR B-LYMPHOBLASTIC LYMPHOMA RECURRENT 15
366 SUBARACHNOID HAEMORRHAGE 15
367 SYSTEMIC CANDIDA 15
368 TRANSIENT ISCHAEMIC ATTACK 15
369 URINARY RETENTION 15
370 VIRAL INFECTION 15
371 CHLOROMA 14
372 CYTOMEGALOVIRUS TEST POSITIVE 14
373 HAEMOLYSIS 14
374 HEPATITIS 14
375 HYPOALBUMINAEMIA 14
376 KLEBSIELLA BACTERAEMIA 14
377 PRODUCT CONTAINER ISSUE 14
378 RASH ERYTHEMATOUS 14
379 RESPIRATORY TRACT INFECTION 14
380 SKIN EXFOLIATION 14
381 THERAPEUTIC RESPONSE DELAYED 14
382 TRACHEITIS 14
383 URINARY INCONTINENCE 14
384 VASCULAR DEVICE INFECTION 14
385 VASCULAR DEVICE OCCLUSION 14
386 B-LYMPHOCYTE COUNT DECREASED 13
387 BLISTER 13
388 BLOOD CULTURE POSITIVE 13
389 CARDIO-RESPIRATORY ARREST 13
390 CARDIOGENIC SHOCK 13
391 DRUG EFFECT LESS THAN EXPECTED 13
392 DRY MOUTH 13
393 ESCHERICHIA SEPSIS 13
394 GLOMERULAR FILTRATION RATE DECREASED 13
395 HEPATOMEGALY 13
396 INCONTINENCE 13
397 INTERLEUKIN LEVEL INCREASED 13
398 LACTIC ACIDOSIS 13
399 LUNG INFECTION 13
400 MELAENA 13
401 METASTASES TO BONE MARROW 13
402 MOBILITY DECREASED 13
403 MUSCULOSKELETAL PAIN 13
404 MYOCARDIAL INFARCTION 13
405 NASOPHARYNGITIS 13
406 NEUTROPENIC COLITIS 13
407 PNEUMONIA ASPIRATION 13
408 SECOND PRIMARY MALIGNANCY 13
409 THERAPEUTIC PRODUCT EFFECT DECREASED 13
410 TRANSPLANT 13
411 UNDERDOSE 13
412 ACUTE HEPATIC FAILURE 12
413 ACUTE LEUKAEMIA 12
414 CARDIAC DISORDER 12
415 DEPRESSION 12
416 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 12
417 FACE OEDEMA 12
418 HYPOPHOSPHATAEMIA 12
419 HYPOPROTEINAEMIA 12
420 IMMUNOGLOBULINS DECREASED 12
421 IMMUNOSUPPRESSION 12
422 IRRITABILITY 12
423 KLEBSIELLA INFECTION 12
424 LIPASE INCREASED 12
425 MALNUTRITION 12
426 MENINGITIS ASEPTIC 12
427 METASTASES TO MUSCLE 12
428 METASTASES TO RETROPERITONEUM 12
429 METASTASES TO SPLEEN 12
430 MONOCYTOSIS 12
431 PRODUCT ADMINISTRATION INTERRUPTED 12
432 PROTHROMBIN TIME PROLONGED 12
433 RED BLOOD CELL COUNT DECREASED 12
434 RENAL INJURY 12
435 RESTLESSNESS 12
436 SINUS TACHYCARDIA 12
437 STEM CELL TRANSPLANT 12
438 TRICHOSPORON INFECTION 12
439 ABNORMAL BEHAVIOUR 11
440 AGRANULOCYTOSIS 11
441 BLOOD ALBUMIN DECREASED 11
442 BLOOD FIBRINOGEN DECREASED 11
443 BONE LESION 11
444 CATHETER SITE HAEMORRHAGE 11
445 CEREBRAL INFARCTION 11
446 CHOLELITHIASIS 11
447 CSF LYMPHOCYTE COUNT INCREASED 11
448 CYTOMEGALOVIRUS VIRAEMIA 11
449 DECREASED IMMUNE RESPONSIVENESS 11
450 DIABETES MELLITUS 11
451 DISEASE COMPLICATION 11
452 DRUG EFFECT DECREASED 11
453 EPSTEIN-BARR VIRUS INFECTION 11
454 EYE PAIN 11
455 FLUID RETENTION 11
456 GASTROINTESTINAL TOXICITY 11
457 GRAFT VERSUS HOST DISEASE IN LUNG 11
458 HUMAN HERPESVIRUS 6 ENCEPHALITIS 11
459 HYPERCALCAEMIA 11
460 HYPERPYREXIA 11
461 HYPOMAGNESAEMIA 11
462 ILLNESS 11
463 LEUKAEMIC INFILTRATION RENAL 11
464 METABOLIC ENCEPHALOPATHY 11
465 METASTASES TO LIVER 11
466 METASTASES TO LUNG 11
467 MOVEMENT DISORDER 11
468 NO THERAPEUTIC RESPONSE 11
469 ORGANISING PNEUMONIA 11
470 PNEUMOTHORAX 11
471 PROCALCITONIN INCREASED 11
472 PULMONARY HYPERTENSION 11
473 PULMONARY TOXICITY 11
474 SPONTANEOUS BACTERIAL PERITONITIS 11
475 VENTRICULAR TACHYCARDIA 11
476 ABDOMINAL DISTENSION 10
477 ACCIDENTAL OVERDOSE 10
478 AGGRESSION 10
479 AMYLASE INCREASED 10
480 ARRHYTHMIA 10
481 BLOOD POTASSIUM DECREASED 10
482 BRAIN HERNIATION 10
483 CATHETER SITE INFECTION 10
484 CHEST DISCOMFORT 10
485 CIRCULATORY COLLAPSE 10
486 DEVICE RELATED SEPSIS 10
487 DRUG ERUPTION 10
488 DRUG LEVEL INCREASED 10
489 ELECTROCARDIOGRAM QT PROLONGED 10
490 ENDOCARDITIS 10
491 ENGRAFTMENT SYNDROME 10
492 ENTEROCOLITIS 10
493 HEPATOCELLULAR INJURY 10
494 HOT FLUSH 10
495 HUMAN HERPESVIRUS 6 INFECTION 10
496 HYPOPHAGIA 10
497 ILEUS 10
498 JAUNDICE 10
499 JAW OPERATION 10
500 JUGULAR VEIN THROMBOSIS 10
501 MENINGITIS BACTERIAL 10
502 NEPHROPATHY TOXIC 10
503 PAPILLOEDEMA 10
504 PERICARDITIS 10
505 PNEUMATOSIS INTESTINALIS 10
506 PNEUMONIA VIRAL 10
507 PULSELESS ELECTRICAL ACTIVITY 10
508 QUADRIPLEGIA 10
509 RED CELL DISTRIBUTION WIDTH INCREASED 10
510 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10
511 SARS-COV-2 TEST POSITIVE 10
512 SKIN ULCER 10
513 SLOW RESPONSE TO STIMULI 10
514 TACHYPNOEA 10
515 TINNITUS 10
516 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 9
517 BLOOD CALCIUM INCREASED 9
518 BLOOD CHLORIDE INCREASED 9
519 BLOOD LACTIC ACID INCREASED 9
520 BLOOD TRIGLYCERIDES INCREASED 9
521 BRAIN NATRIURETIC PEPTIDE INCREASED 9
522 CENTRAL NERVOUS SYSTEM LESION 9
523 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 9
524 CHRONIC MYELOID LEUKAEMIA RECURRENT 9
525 CYTOKINE STORM 9
526 DEVICE DISLOCATION 9
527 DEVICE RELATED BACTERAEMIA 9
528 DEVICE USE ERROR 9
529 DISSEMINATED CRYPTOCOCCOSIS 9
530 ECZEMA 9
531 EMOTIONAL DISTRESS 9
532 FEBRILE INFECTION 9
533 FIBRIN D DIMER INCREASED 9
534 GASTROINTESTINAL INFECTION 9
535 GRAFT VERSUS HOST DISEASE IN EYE 9
536 HAEMANGIOMA 9
537 HAEMATEMESIS 9
538 HICCUPS 9
539 HYPOTHERMIA 9
540 INCORRECT PRODUCT ADMINISTRATION DURATION 9
541 INFLUENZA LIKE ILLNESS 9
542 INFUSION SITE EXTRAVASATION 9
543 INTENSIVE CARE 9
544 MYOCARDIAL INJURY 9
545 MYOPATHY 9
546 NEUTROPHIL COUNT ABNORMAL 9
547 OPTIC NEURITIS 9
548 ORAL CANDIDIASIS 9
549 OSTEOMYELITIS 9
550 OSTEONECROSIS 9
551 PALPITATIONS 9
552 PARTIAL SEIZURES 9
553 PERIPHERAL MOTOR NEUROPATHY 9
554 POLYNEUROPATHY 9
555 RADICULOPATHY 9
556 SCLERODERMA 9
557 SKIN DISORDER 9
558 SKIN INFECTION 9
559 SPINAL CORD DISORDER 9
560 STAPHYLOCOCCAL SEPSIS 9
561 SWELLING FACE 9
562 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 9
563 TRANSPLANT EVALUATION 9
564 VENTRICULAR ARRHYTHMIA 9
565 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 8
566 ACUTE MYELOID LEUKAEMIA RECURRENT 8
567 ADRENAL INSUFFICIENCY 8
568 ANAL INCONTINENCE 8
569 ARTERIOSCLEROSIS CORONARY ARTERY 8
570 ASPERGILLUS TEST POSITIVE 8
571 BLOOD FIBRINOGEN INCREASED 8
572 BLOOD URIC ACID INCREASED 8
573 BODY TEMPERATURE ABNORMAL 8
574 BONE MARROW NECROSIS 8
575 CARDIAC VENTRICULAR THROMBOSIS 8
576 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 8
577 DEAFNESS 8
578 DEVICE MALFUNCTION 8
579 DISCOMFORT 8
580 DYSKINESIA 8
581 ENTEROCOCCAL BACTERAEMIA 8
582 FEELING COLD 8
583 FULL BLOOD COUNT ABNORMAL 8
584 HAEMATOCRIT DECREASED 8
585 HEPATOSPLENOMEGALY 8
586 HYPERKALAEMIA 8
587 ILEUS PARALYTIC 8
588 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8
589 INTENTION TREMOR 8
590 INTENTIONAL PRODUCT MISUSE 8
591 LUNG CONSOLIDATION 8
592 LYMPHOCYTE COUNT INCREASED 8
593 LYMPHOMA 8
594 MASS 8
595 MEDICATION ERROR 8
596 MENTAL IMPAIRMENT 8
597 METASTASES TO CENTRAL NERVOUS SYSTEM 8
598 MIGRAINE 8
599 MONOCYTE COUNT DECREASED 8
600 MUSCULOSKELETAL DISORDER 8
601 MUTISM 8
602 MYELOPATHY 8
603 NEUROLOGICAL DECOMPENSATION 8
604 ORAL HERPES 8
605 PERIODONTITIS 8
606 PHILADELPHIA POSITIVE ACUTE LYMPHOCYTIC LEUKAEMIA 8
607 POST PROCEDURAL COMPLICATION 8
608 PRODUCT TEMPERATURE EXCURSION ISSUE 8
609 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 8
610 PSEUDOMONAL SEPSIS 8
611 PULMONARY ALVEOLAR HAEMORRHAGE 8
612 PULMONARY FIBROSIS 8
613 SUBDURAL HYGROMA 8
614 ABDOMINAL DISCOMFORT 7
615 ABDOMINAL PAIN LOWER 7
616 ACQUIRED GENE MUTATION 7
617 ADENOVIRAL HAEMORRHAGIC CYSTITIS 7
618 ADRENOMEGALY 7
619 ARACHNOIDITIS 7
620 BLINDNESS 7
621 BLOOD LACTATE DEHYDROGENASE DECREASED 7
622 BLOOD UREA INCREASED 7
623 BONE MARROW DISORDER 7
624 CARDIAC DYSFUNCTION 7
625 CARDIOVASCULAR DISORDER 7
626 CATARACT 7
627 CEREBRAL ISCHAEMIA 7
628 CEREBROVASCULAR DISORDER 7
629 CHOLECYSTITIS 7
630 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 7
631 CHRONIC KIDNEY DISEASE 7
632 CONTUSION 7
633 COORDINATION ABNORMAL 7
634 CRYING 7
635 CYTOMEGALOVIRUS COLITIS 7
636 DIAPHRAGMATIC DISORDER 7
637 DISSEMINATED MUCORMYCOSIS 7
638 DRUG HYPERSENSITIVITY 7
639 DYSMETRIA 7
640 DYSSTASIA 7
641 ENTEROBACTER INFECTION 7
642 ENTEROCOLITIS INFECTIOUS 7
643 ESCHERICHIA INFECTION 7
644 FACIAL PARESIS 7
645 FIBRIN DEGRADATION PRODUCTS INCREASED 7
646 FLUID OVERLOAD 7
647 GASTRITIS 7
648 GASTROINTESTINAL INJURY 7
649 HAEMATOCHEZIA 7
650 HAEMATOMA 7
651 HAEMOGLOBIN ABNORMAL 7
652 HEPATIC CALCIFICATION 7
653 HEPATITIS B REACTIVATION 7
654 HYPERLEUKOCYTOSIS 7
655 HYPERSOMNIA 7
656 HYPERURICAEMIA 7
657 HYPOFIBRINOGENAEMIA 7
658 HYPOGLYCAEMIA 7
659 HYPOTHYROIDISM 7
660 IIIRD NERVE PARALYSIS 7
661 LANGUAGE DISORDER 7
662 MENINGITIS 7
663 METAMYELOCYTE COUNT INCREASED 7
664 METAPNEUMOVIRUS INFECTION 7
665 MUSCLE INJURY 7
666 MYELOCYTE COUNT INCREASED 7
667 MYELOID LEUKAEMIA 7
668 MYOCLONUS 7
669 NEOPLASM 7
670 NEOPLASM MALIGNANT 7
671 PANCREATITIS CHRONIC 7
672 PARAINFLUENZAE VIRUS INFECTION 7
673 PARVOVIRUS B19 INFECTION 7
674 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 7
675 PLASMA CELL MYELOMA 7
676 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 7
677 PRODUCTIVE COUGH 7
678 PROTEIN TOTAL DECREASED 7
679 PSYCHOTIC DISORDER 7
680 PULMONARY MASS 7
681 RASH PRURITIC 7
682 REFUSAL OF TREATMENT BY PATIENT 7
683 RENAL DISORDER 7
684 SKIN REACTION 7
685 SOFT TISSUE INFECTION 7
686 SUBDURAL HAEMORRHAGE 7
687 THERAPY CESSATION 7
688 TOXIC ENCEPHALOPATHY 7
689 ACHROMOBACTER INFECTION 6
690 ACUTE MYELOMONOCYTIC LEUKAEMIA 6
691 ACUTE MYOCARDIAL INFARCTION 6
692 ALANINE AMINOTRANSFERASE ABNORMAL 6
693 APLASIA 6
694 APPENDICITIS 6
695 ASTHMA 6
696 BASAL CELL CARCINOMA 6
697 BILIRUBIN CONJUGATED INCREASED 6
698 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 6
699 CARDIAC FAILURE ACUTE 6
700 CEREBRAL ATROPHY 6
701 CHOLANGITIS 6
702 CHRONIC MYELOID LEUKAEMIA 6
703 CLOSTRIDIUM COLITIS 6
704 COMMUNICATION DISORDER 6
705 COMPLICATIONS OF TRANSPLANT SURGERY 6
706 COMPRESSION FRACTURE 6
707 COSTAL CARTILAGE FRACTURE 6
708 CUTANEOUS VASCULITIS 6
709 DEVICE CONNECTION ISSUE 6
710 DIPLOPIA 6
711 DISTURBANCE IN ATTENTION 6
712 DIVERTICULITIS 6
713 DYSPHORIA 6
714 DYSTONIA 6
715 DYSURIA 6
716 EJECTION FRACTION DECREASED 6
717 ELECTROLYTE IMBALANCE 6
718 EUPHORIC MOOD 6
719 EXPOSURE VIA SKIN CONTACT 6
720 EYE DISORDER 6
721 FEEDING DISORDER 6
722 GAIT INABILITY 6
723 GRANULOCYTOPENIA 6
724 HAEMOLYTIC ANAEMIA 6
725 HALLUCINATION, VISUAL 6
726 HAPTOGLOBIN DECREASED 6
727 HEMIPLEGIA 6
728 HEPATOBILIARY DISEASE 6
729 HOSPICE CARE 6
730 HYPERTHERMIA 6
731 HYPOACUSIS 6
732 IMMUNE THROMBOCYTOPENIA 6
733 INTERNATIONAL NORMALISED RATIO INCREASED 6
734 INTERVERTEBRAL DISC PROTRUSION 6
735 ISCHAEMIC STROKE 6
736 JOINT SWELLING 6
737 KLEBSIELLA SEPSIS 6
738 LACTOSE INTOLERANCE 6
739 LARGE INTESTINE PERFORATION 6
740 LEFT VENTRICULAR DYSFUNCTION 6
741 LEUKAEMIC INFILTRATION 6
742 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6
743 LYMPHOCYTIC LEUKAEMIA 6
744 MOTOR DYSFUNCTION 6
745 MUSCULOSKELETAL STIFFNESS 6
746 NECK PAIN 6
747 NERVOUSNESS 6
748 NIGHT SWEATS 6
749 NO ADVERSE EVENT 6
750 NON-CARDIAC CHEST PAIN 6
751 ORGAN FAILURE 6
752 OSTEOPENIA 6
753 PARALYSIS 6
754 PERONEAL NERVE PALSY 6
755 PETIT MAL EPILEPSY 6
756 PNEUMONIA KLEBSIELLA 6
757 POST PROCEDURAL INFECTION 6
758 PSYCHOMOTOR HYPERACTIVITY 6
759 RASH PAPULAR 6
760 RECURRENT CANCER 6
761 RESPIRATORY DISORDER 6
762 SUPERIOR SAGITTAL SINUS THROMBOSIS 6
763 SUPRAVENTRICULAR TACHYCARDIA 6
764 SWELLING 6
765 TORSADE DE POINTES 6
766 TRANSPLANT REJECTION 6
767 TREATMENT NONCOMPLIANCE 6
768 VERTIGO 6
769 VIRAL UPPER RESPIRATORY TRACT INFECTION 6
770 ACUTE PSYCHOSIS 5
771 AMMONIA INCREASED 5
772 ANAPHYLACTIC SHOCK 5
773 ANGER 5
774 ASPARTATE AMINOTRANSFERASE ABNORMAL 5
775 ATRIAL THROMBOSIS 5
776 BLAST CELL COUNT DECREASED 5
777 BLOOD MAGNESIUM DECREASED 5
778 BONE MARROW TRANSPLANT 5
779 BURKITT^S LYMPHOMA 5
780 CARDIAC FAILURE CONGESTIVE 5
781 CARDIOMYOPATHY 5
782 CATHETER SITE RASH 5
783 CATHETER SITE THROMBOSIS 5
784 CD19 ANTIGEN LOSS 5
785 CD19 LYMPHOCYTES DECREASED 5
786 CELL DEATH 5
787 CENTRAL NERVOUS SYSTEM INFECTION 5
788 CHEMOTHERAPY 5
789 CORONARY ARTERY STENOSIS 5
790 CRYPTOCOCCAL FUNGAEMIA 5
791 CSF TEST ABNORMAL 5
792 DEPRESSED MOOD 5
793 DEVICE PROGRAMMING ERROR 5
794 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 5
795 DRUG ADMINISTRATION ERROR 5
796 DYSPEPSIA 5
797 EATING DISORDER 5
798 ELECTROENCEPHALOGRAM ABNORMAL 5
799 ENDOTRACHEAL INTUBATION 5
800 ESCHERICHIA TEST POSITIVE 5
801 EXTRA DOSE ADMINISTERED 5
802 EXTRADURAL HAEMATOMA 5
803 GASTROENTERITIS 5
804 GASTROOESOPHAGEAL REFLUX DISEASE 5
805 GENERALISED OEDEMA 5
806 GINGIVAL PAIN 5
807 HAEMODYNAMIC INSTABILITY 5
808 HAEMORRHAGIC DISORDER 5
809 HEART RATE DECREASED 5
810 HEPATIC ENZYME ABNORMAL 5
811 HEPATIC NECROSIS 5
812 HEPATIC STEATOSIS 5
813 HEPATITIS B 5
814 HYDROCEPHALUS 5
815 HYPORESPONSIVE TO STIMULI 5
816 INFLAMMATORY BOWEL DISEASE 5
817 INTENTIONAL PRODUCT USE ISSUE 5
818 INTESTINAL HAEMORRHAGE 5
819 INTESTINAL OBSTRUCTION 5
820 LOWER RESPIRATORY TRACT INFECTION FUNGAL 5
821 LUNG OPACITY 5
822 METASTASES TO MENINGES 5
823 MUSCLE STRENGTH ABNORMAL 5
824 MUSCULOSKELETAL CHEST PAIN 5
825 MYOCARDITIS 5
826 NEEDLE ISSUE 5
827 NEURODERMATITIS 5
828 NEUTROPENIC INFECTION 5
829 OBLITERATIVE BRONCHIOLITIS 5
830 OCULAR HYPERAEMIA 5
831 PAIN IN JAW 5
832 PATHOGEN RESISTANCE 5
833 PLEURITIC PAIN 5
834 POLYOMAVIRUS VIRAEMIA 5
835 PORTAL VEIN THROMBOSIS 5
836 POST-DEPLETION B-CELL RECOVERY 5
837 POSTURING 5
838 PRODUCT LABEL CONFUSION 5
839 PRODUCT PREPARATION ISSUE 5
840 PRURITUS ALLERGIC 5
841 PSEUDOMONAL BACTERAEMIA 5
842 RALES 5
843 RESPIRATORY ARREST 5
844 RHINORRHOEA 5
845 SCHIZOPHRENIA 5
846 SECONDARY IMMUNODEFICIENCY 5
847 SKIN DISCOLOURATION 5
848 SLOW SPEECH 5
849 SPINAL CORD COMPRESSION 5
850 STENOTROPHOMONAS INFECTION 5
851 STREPTOCOCCAL BACTERAEMIA 5
852 SUICIDAL IDEATION 5
853 THINKING ABNORMAL 5
854 TONIC CONVULSION 5
855 TRANSPLANT DYSFUNCTION 5
856 TROPONIN INCREASED 5
857 TUMOUR ASSOCIATED FEVER 5
858 URTICARIA 5
859 VASCULAR ACCESS COMPLICATION 5
860 VASCULAR ACCESS SITE OCCLUSION 5
861 VENTRICULAR EXTRASYSTOLES 5
862 VENTRICULAR FIBRILLATION 5
863 VIRAL HAEMORRHAGIC CYSTITIS 5
864 VISUAL ACUITY REDUCED 5
865 WHEEZING 5
866 ABASIA 4
867 ABDOMINAL INFECTION 4
868 ABSCESS 4
869 ACTIVITIES OF DAILY LIVING IMPAIRED 4
870 ACUTE MONOCYTIC LEUKAEMIA 4
871 ACUTE PULMONARY OEDEMA 4
872 ALLOGENIC STEM CELL TRANSPLANTATION 4
873 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 4
874 APHONIA 4
875 ARTHRITIS BACTERIAL 4
876 ATELECTASIS 4
877 AUTOIMMUNE DISORDER 4
878 BLOOD CALCIUM DECREASED 4
879 BLOOD CREATININE ABNORMAL 4
880 BLOOD CREATININE DECREASED 4
881 BLOOD DISORDER 4
882 BLOOD POTASSIUM INCREASED 4
883 BLOOD PRESSURE ABNORMAL 4
884 BLOOD PRODUCT TRANSFUSION DEPENDENT 4
885 BLOOD SODIUM DECREASED 4
886 BRADYPHRENIA 4
887 BRONCHOSPASM 4
888 C-REACTIVE PROTEIN 4
889 CANDIDA SEPSIS 4
890 CEREBELLAR SYNDROME 4
891 CEREBRAL ASPERGILLOSIS 4
892 CEREBRAL VENOUS SINUS THROMBOSIS 4
893 CHRONIC LYMPHOCYTIC LEUKAEMIA 4
894 COLITIS ULCERATIVE 4
895 COMPLICATIONS OF BONE MARROW TRANSPLANT 4
896 CSF PROTEIN INCREASED 4
897 CYSTITIS 4
898 CYSTITIS VIRAL 4
899 CYTOMEGALOVIRUS ENTEROCOLITIS 4
900 DECREASED EYE CONTACT 4
901 DECREASED INTEREST 4
902 DIALYSIS 4
903 DILATED CARDIOMYOPATHY 4
904 DISSOCIATION 4
905 DRUG DOSE OMISSION 4
906 DYSPNOEA EXERTIONAL 4
907 ENTERITIS 4
908 EPSTEIN-BARR VIRAEMIA 4
909 ERYTHROPOIESIS ABNORMAL 4
910 EYE MOVEMENT DISORDER 4
911 EYE SWELLING 4
912 EYELID PTOSIS 4
913 FEBRILE CONVULSION 4
914 FEMUR FRACTURE 4
915 FRACTURE 4
916 FUNGAL SEPSIS 4
917 GAZE PALSY 4
918 GERM CELL NEOPLASM 4
919 GUILLAIN-BARRE SYNDROME 4
920 HAEMATOPOIETIC STEM CELL MOBILISATION 4
921 HAEMOLYTIC TRANSFUSION REACTION 4
922 HAEMOPTYSIS 4
923 HALLUCINATION, AUDITORY 4
924 HEPATITIS TOXIC 4
925 HIP FRACTURE 4
926 HYPERFERRITINAEMIA 4
927 HYPERKERATOSIS 4
928 HYPERLIPIDAEMIA 4
929 HYPERTROPHY 4
930 HYPOAESTHESIA ORAL 4
931 HYPOVOLAEMIC SHOCK 4
932 IMMUNE SYSTEM DISORDER 4
933 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4
934 INCOHERENT 4
935 INCORRECT PRODUCT STORAGE 4
936 INFECTION IN AN IMMUNOCOMPROMISED HOST 4
937 INFERTILITY FEMALE 4
938 INFUSION SITE PAIN 4
939 INTRA-ABDOMINAL HAEMORRHAGE 4
940 KIDNEY ENLARGEMENT 4
941 LIMB DISCOMFORT 4
942 LOCALISED INFECTION 4
943 LYMPHOCYTE MORPHOLOGY ABNORMAL 4
944 MARROW HYPERPLASIA 4
945 METABOLIC ACIDOSIS 4
946 MONOPARESIS 4
947 MOUTH HAEMORRHAGE 4
948 MOUTH ULCERATION 4
949 NASAL CONGESTION 4
950 OROPHARYNGEAL PAIN 4
951 PAPULE 4
952 PARAKERATOSIS 4
953 PETECHIAE 4
954 PNEUMONIA BACTERIAL 4
955 PNEUMONIA CYTOMEGALOVIRAL 4
956 POSTICTAL STATE 4
957 PROCEDURAL PAIN 4
958 PRODUCT AVAILABILITY ISSUE 4
959 PRODUCT DISPENSING ERROR 4
960 PRODUCT DOSE OMISSION IN ERROR 4
961 PROTEIN TOTAL INCREASED 4
962 PSORIASIS 4
963 REFRACTORY CANCER 4
964 RESPIRATORY TRACT INFECTION VIRAL 4
965 RETROPERITONEAL MASS 4
966 SECONDARY HYPERTHYROIDISM 4
967 SINUS BRADYCARDIA 4
968 SINUSITIS FUNGAL 4
969 SKIN HYPERPIGMENTATION 4
970 STAPHYLOCOCCUS TEST POSITIVE 4
971 STRESS 4
972 SUPERINFECTION BACTERIAL 4
973 SYSTEMIC SCLERODERMA 4
974 T-LYMPHOCYTE COUNT DECREASED 4
975 TEMPERATURE INTOLERANCE 4
976 THERAPY CHANGE 4
977 TOTAL CHOLESTEROL/HDL RATIO DECREASED 4
978 UPPER GASTROINTESTINAL HAEMORRHAGE 4
979 VARICELLA ZOSTER VIRUS INFECTION 4
980 VIRAEMIA 4
981 VITAMIN D DEFICIENCY 4
982 WHITE BLOOD CELL DISORDER 4
983 ABSCESS LIMB 3
984 ACIDOSIS 3
985 AFFECT LABILITY 3
986 AGNOSIA 3
987 ANAL ABSCESS 3
988 ANAPHYLACTIC REACTION 3
989 ANGIOCENTRIC LYMPHOMA 3
990 ANGIOEDEMA 3
991 ANGIOPATHY 3
992 ANION GAP INCREASED 3
993 APATHY 3
994 APHTHOUS ULCER 3
995 APLASTIC ANAEMIA 3
996 ARTERIAL HAEMORRHAGE 3
997 ARTERIAL OCCLUSIVE DISEASE 3
998 ARTERITIS 3
999 ARTHRITIS 3